Latest from Corporate Social
New insights and informed opinions from professionals across the working world.
Cybersecurity is not just a complex field that should be understood and implemented only by large organizations or specialists. It's a must-know practical online safety guide that should be understood and made available to everyone with a digital presence. "Phish N’ Chips" offers bite-sized, relatable insights into navigating the internet securely, using everyday examples and stories. Think of it as your friendly guide to understanding online threats and protecting yourself without needing a degree in IT or cybersecurity.
Bloom43 is transforming breast surgery preparation with a prehabilitation platform that combines a wearable medical device and guided digital support. By strengthening tissue resilience before surgery and empowering patients through an 8-week companion program, Bloom43 is improving recovery, reducing complications, and redefining how modern surgical care begins, long before the first incision.
VoxelGrids, backed by Zoho, has deployed India’s first indigenously designed and manufactured 1.5T MRI scanner at the Chandrapur Cancer Care Foundation near Nagpur. Built through over a decade of R and D, the system claims major cost advantages by eliminating liquid helium, and the company is now developing a containerised mobile MRI to expand diagnostic access in remote regions.
Liquidia’s L606 is a clear bet that the next leap in inhaled pulmonary hypertension therapy will come from making treprostinil easier to sustain, not from reinventing the molecule. The real proof will be whether extended exposure translates into better titration, adherence, and durable outcomes in everyday clinical use.
Symvess signals a shift in vascular repair from permanent synthetic grafts toward acellular, tissue engineered conduits designed for host remodeling. By retaining an extracellular matrix “tissue frame,” the approach aims to support integration while reducing long-term foreign body complications. FDA approval makes this a validated clinical category, not just an experimental idea. The key questions now are consistency across real-world patients and sites, and long-horizon durability once remodeling is established.